New data from the PROCLIPI study has shown a meaningful overall survival benefit for patients with advanced cutaneous T-cell lymphoma (CTCL) treated with POTELIGEO (mogamulizumab). The findings were ...

SAN ANTONIO – Graffiti linked to the nationwide “No Kings” protests against the Trump administration was sprayed throughout the North Side on Saturday, including at a church and on several walls in ...